BE689995A - - Google Patents

Info

Publication number
BE689995A
BE689995A BE689995DA BE689995A BE 689995 A BE689995 A BE 689995A BE 689995D A BE689995D A BE 689995DA BE 689995 A BE689995 A BE 689995A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE689995A publication Critical patent/BE689995A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/58Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with a nitrogen atom, which is a member of a hetero ring, attached in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE689995D 1965-11-24 1966-11-21 BE689995A (US07655688-20100202-C00086.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US509627A US3303193A (en) 1965-11-24 1965-11-24 Derivatives of cephalosporanic acid

Publications (1)

Publication Number Publication Date
BE689995A true BE689995A (US07655688-20100202-C00086.png) 1967-05-22

Family

ID=24027438

Family Applications (1)

Application Number Title Priority Date Filing Date
BE689995D BE689995A (US07655688-20100202-C00086.png) 1965-11-24 1966-11-21

Country Status (13)

Country Link
US (1) US3303193A (US07655688-20100202-C00086.png)
BE (1) BE689995A (US07655688-20100202-C00086.png)
BR (1) BR6684800D0 (US07655688-20100202-C00086.png)
CH (1) CH477476A (US07655688-20100202-C00086.png)
CY (1) CY667A (US07655688-20100202-C00086.png)
DE (1) DE1670163C3 (US07655688-20100202-C00086.png)
DK (1) DK112944B (US07655688-20100202-C00086.png)
ES (1) ES333664A1 (US07655688-20100202-C00086.png)
FR (2) FR1516019A (US07655688-20100202-C00086.png)
GB (1) GB1162247A (US07655688-20100202-C00086.png)
MY (1) MY7300189A (US07655688-20100202-C00086.png)
NL (2) NL6616444A (US07655688-20100202-C00086.png)
SE (1) SE348203B (US07655688-20100202-C00086.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061862A (en) * 1975-10-06 1977-12-06 Bristol-Myers Company Derivatives of 7-(cyclized)phenylglycyl-3-triazolo-thio methyl cephalosporin
US4064345A (en) * 1975-12-12 1977-12-20 Bristol-Myers Company Cephalosporins derivatives 7-cyclized α-amino-3-heterothio
US4002748A (en) * 1976-01-19 1977-01-11 Eli Lilly And Company Method of preparing sterile essentially amorphous cefazolin for reconstitution for parenteral administration
JPS54112892A (en) * 1978-02-23 1979-09-04 Shionogi & Co Ltd Substituted imidazolidinyl-3-chloro-3-cephem-4-carboxylic acid
US4288590A (en) * 1980-02-14 1981-09-08 Bristol-Myers Company 7-[Dα-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-α-arylacetamido]-3-(N,N-dimethyl-aminomethylpyridinium) methyl-3-cephem-4-carboxylates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985648A (en) * 1958-10-06 1961-05-23 Doyle Frank Peter Alpha-aminobenzylpenicillins
GB985747A (en) * 1961-09-11 1965-03-10 Lilly Co Eli Cephalosporin compounds
US3198804A (en) * 1963-01-25 1965-08-03 Bristol Myers Co alpha-aminomethylpenicillin derivatives

Also Published As

Publication number Publication date
BR6684800D0 (pt) 1973-12-18
NL125838C (US07655688-20100202-C00086.png)
GB1162247A (en) 1969-08-20
NL6616444A (US07655688-20100202-C00086.png) 1967-05-25
DE1670163A1 (de) 1970-08-13
DE1670163B2 (de) 1973-04-26
CY667A (en) 1972-12-13
MY7300189A (en) 1973-12-31
CH477476A (de) 1969-08-31
DE1670163C3 (de) 1973-11-29
DK112944B (da) 1969-02-03
FR1516019A (fr) 1968-03-08
SE348203B (US07655688-20100202-C00086.png) 1972-08-28
US3303193A (en) 1967-02-07
ES333664A1 (es) 1967-12-01
FR6118M (US07655688-20100202-C00086.png) 1968-06-17

Similar Documents

Publication Publication Date Title
JPS417433Y1 (US07655688-20100202-C00086.png)
AU5800565A (US07655688-20100202-C00086.png)
SE306818B (US07655688-20100202-C00086.png)
BE657977A (US07655688-20100202-C00086.png)
BE659955A (US07655688-20100202-C00086.png)
BE664086A (US07655688-20100202-C00086.png)
BE666367A (US07655688-20100202-C00086.png)
BE667030A (US07655688-20100202-C00086.png)
BE668137A (US07655688-20100202-C00086.png)
BE668772A (US07655688-20100202-C00086.png)
BE669260A (US07655688-20100202-C00086.png)
BE670428A (US07655688-20100202-C00086.png)
BE670781A (US07655688-20100202-C00086.png)
BE670827A (US07655688-20100202-C00086.png)
BE672036A (US07655688-20100202-C00086.png)
BE672117A (US07655688-20100202-C00086.png)
BE672809A (US07655688-20100202-C00086.png)
BE673393A (US07655688-20100202-C00086.png)
BE673736A (US07655688-20100202-C00086.png)
BE673764A (US07655688-20100202-C00086.png)
BE673847A (US07655688-20100202-C00086.png)
BE673987A (US07655688-20100202-C00086.png)
BE674044A (US07655688-20100202-C00086.png)
BE674057A (US07655688-20100202-C00086.png)
BE674116A (US07655688-20100202-C00086.png)